SLDB
SLDB
US83422E2046
Solid Biosciences Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
179.206.000 129.728.000
38.1%
Operating Income -179.206.000 -129.728.000
38.1%
Pretax Income -174.325.000 -124.697.000
39.8%
Net Income Common Stockholders -174.325.000 -124.697.000
39.8%
-- --
--
-- --
--
ende